Sera Prognostics (NASDAQ: SERA)
$10.34
(3.0%)
$0.30
Price as of April 25, 2024, 4:00 p.m. ET
Sera Prognostics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Sera Prognostics Company Info
Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.
News & Analysis
Valuation
Earnings Transcripts
Sera Prognostics, Inc. (SERA) Q2 2022 Earnings Call Transcript
SERA earnings call for the period ending June 30, 2022.
Motley Fool Transcribing | Aug 11, 2022
Sera Prognostics, Inc. (SERA) Q1 2022 Earnings Call Transcript
SERA earnings call for the period ending March 31, 2022.
Motley Fool Transcribing | May 12, 2022
Sera Prognostics, Inc. (SERA) Q4 2021 Earnings Call Transcript
SERA earnings call for the period ending December 31, 2021.
Motley Fool Transcribing | Mar 30, 2022
Sera Prognostics, Inc. (SERA) Q3 2021 Earnings Call Transcript
SERA earnings call for the period ending September 30, 2021.
Motley Fool Transcribing | Nov 10, 2021
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.